Epidemiology and Management of Medication-overuse Headache in the General Population

Overview

Journal Neurol Sci

Specialty Neurology

Date 2019 Mar 20

PMID 30887240

Citations 10

Authors

Michael Bjorn Russell

Affiliations

Soon will be listed here.

Abstract

Medication-overuse headache is a worldwide challenge as it affects 1-2% of the general population. Some people are more prone to medication overuse, which can be ascertained by applying five simple questions about dependence. Detoxification of the overused medication is a cheap and effective treatment strategy. A short advice seems to be sufficient for people from the general population whom seek their general practitioner. Treatment is often more complicated in neurologist and hospital settings, most likely due to a combination of treatment failure in general practice and co-morbidity of other disorders including different types of headaches.

Citing Articles

Network analysis of headache diagnoses using international classification of headache disorders, 3rd edition.

Zhang P, Berk T Front Neurol. 2025; 16:1526037.

PMID: 39949792 PMC: 11824271. DOI: 10.3389/fneur.2025.1526037.

Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalization.

Tanei T, Fuse Y, Maesawa S, Nishimura Y, Ishizaki T, Nagashima Y Heliyon. 2025; 10(22):e40190.

PMID: 39748981 PMC: 11693917. DOI: 10.1016/j.heliyon.2024.e40190.

Prevalence and Awareness of Medication Overuse Headache among Undergraduate Students at the University of Belgrade.

Radojicic A, Milicevic A, Zdraljevic M, Jeremic M, Orlovic D, Mijajlovic M Brain Sci. 2024; 14(9).

PMID: 39335432 PMC: 11429653. DOI: 10.3390/brainsci14090938.

Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study).

Fedeli D, Ciullo G, Demichelis G, Medina Carrion J, Bruzzone M, Ciusani E J Headache Pain. 2024; 25(1):97.

PMID: 38858629 PMC: 11165872. DOI: 10.1186/s10194-024-01803-5.

Treatment patterns and characteristics of patients with migraine: results from a retrospective database study in Japan.

Takizawa T, Kitano T, Iijima M, Togo K, Yonemoto N J Headache Pain. 2024; 25(1):19.

PMID: 38331739 PMC: 10854051. DOI: 10.1186/s10194-024-01722-5.

References

de Las Cuevas C, Sanz E, de la Fuente J, Padilla J, Berenguer J . The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction. 2000; 95(2):245-50. DOI: 10.1046/j.1360-0443.2000.95224511.x. View

Lu S, Fuh J, Chen W, Juang K, Wang S . Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2002; 21(10):980-6. DOI: 10.1046/j.1468-2982.2001.00294.x. View

Kaye S, Darke S . Determining a diagnostic cut-off on the Severity of Dependence Scale (SDS) for cocaine dependence. Addiction. 2002; 97(6):727-31. DOI: 10.1046/j.1360-0443.2002.00121.x. View

Russell M, Rasmussen B, Brennum J, Iversen H, Jensen R, Olesen J . Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 1992; 12(6):369-74. DOI: 10.1111/j.1468-2982.1992.00369.x. View

Peters G, HORTON B . Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin. 1951; 26(9):153-61. View

. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 Suppl 1:9-160. DOI: 10.1111/j.1468-2982.2003.00824.x. View

Colas R, Munoz P, Temprano R, Gomez C, Pascual J . Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004; 62(8):1338-42. DOI: 10.1212/01.wnl.0000120545.45443.93. View

Martin G, Copeland J, Gates P, Gilmour S . The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Drug Alcohol Depend. 2005; 83(1):90-3. DOI: 10.1016/j.drugalcdep.2005.10.014. View

Wang S, Fuh J, Lu S, Juang K . Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology. 2006; 66(2):193-7. DOI: 10.1212/01.wnl.0000183555.54305.fd. View

10.

Lawrinson P, Copeland J, Gerber S, Gilmour S . Determining a cut-off on the Severity of Dependence Scale (SDS) for alcohol dependence. Addict Behav. 2006; 32(7):1474-9. DOI: 10.1016/j.addbeh.2006.09.005. View

11.

Aaseth K, Grande R, Kvaerner K, Gulbrandsen P, Lundqvist C, Russell M . Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008; 28(7):705-13. DOI: 10.1111/j.1468-2982.2008.01577.x. View

12.

Grande R, Aaseth K, Benth J, Gulbrandsen P, Russell M, Lundqvist C . The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache. J Neurol Neurosurg Psychiatry. 2009; 80(7):784-9. DOI: 10.1136/jnnp.2008.168864. View

13.

Aaseth K, Grande R, Lundqvist C, Russell M . What is chronic headache in the general population? The Akershus study of chronic headache. Acta Neurol Scand Suppl. 2009; (189):30-2. DOI: 10.1111/j.1600-0404.2009.01209.x. View

14.

Lundqvist C, Aaseth K, Grande R, Saltyte Benth J, Russell M . The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache. Pain. 2010; 148(3):487-491. DOI: 10.1016/j.pain.2009.12.010. View

15.

Grande R, Aaseth K, Benth J, Lundqvist C, Russell M . Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2010; 18(1):129-37. DOI: 10.1111/j.1468-1331.2010.03094.x. View

16.

Lundqvist C, Benth J, Grande R, Aaseth K, Russell M . An adapted Severity of Dependence Scale is valid for the detection of medication overuse: the Akershus study of chronic headache. Eur J Neurol. 2010; 18(3):512-8. DOI: 10.1111/j.1468-1331.2010.03202.x. View

17.

Evers S, Jensen R . Treatment of medication overuse headache--guideline of the EFNS headache panel. Eur J Neurol. 2011; 18(9):1115-21. DOI: 10.1111/j.1468-1331.2011.03497.x. View

18.

. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9):629-808. DOI: 10.1177/0333102413485658. View

19.

Westergaard M, Hansen E, Glumer C, Olesen J, Jensen R . Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2013; 34(6):409-25. DOI: 10.1177/0333102413512033. View

20.

Tassorelli C, Jensen R, Allena M, De Icco R, Sances G, Katsarava Z . A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia. 2014; 34(9):645-655. DOI: 10.1177/0333102414521508. View